Dr. Charles Zaremba, M.D.
What this data tells you about Dr. Zaremba
Dr. Charles Zaremba is a pathology - anatomic in Harlingen, TX, with 18 years in practice. Based on federal Medicare data, Dr. Zaremba performed 2,078 Medicare services across 607 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zaremba received a total of $33 from 1 pharmaceutical and/or device company across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zaremba is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Flow cytometry, additional marker | 601 | $18 | $166 |
| Infectious disease DNA/RNA test | 364 | $34 | $86 |
| Tissue pathology examination, moderate complexity | 329 | $54 | $290 |
| Yeast/candida DNA test | 140 | $34 | $86 |
| Tissue staining for diagnosis, initial | 93 | $76 | $321 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 84 | $69 | $174 |
| Tissue staining for diagnosis, additional | 66 | $66 | $270 |
| Blood smear interpretation by physician with written report | 46 | $18 | $69 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 40 | $64 | $258 |
| Special stained specimen slides to examine tissue including interpretation and report | 38 | $62 | $236 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 28 | $34 | $86 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 28 | $34 | $86 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 28 | $34 | $86 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 28 | $34 | $86 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 28 | $34 | $86 |
| Flow cytometry technique for dna or cell analysis, first marker | 27 | $54 | $201 |
| Microscopic genetic analysis of tumor, manual | 22 | $90 | $341 |
| Pathology examination of tissue using a microscope, moderately low complexity | 21 | $9 | $204 |
| Pathology examination of tissue using a microscope, moderately high complexity | 19 | $62 | $604 |
| Preparation of tissue for examination by removing any calcium present | 18 | $16 | $59 |
| Bone marrow, smear interpretation | 17 | $53 | $248 |
| Pathology examination of tissue using a microscope, limited examination | 13 | $3 | $98 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zaremba is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zaremba experienced with flow cytometry, additional marker?
Does Dr. Zaremba receive payments from pharmaceutical companies?
How do Dr. Zaremba's costs compare to other pathology - anatomics in Harlingen?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology